Oncopeptides has completed a directed share issue of SEK 314 million

March 22, 2018

Oncopeptides today announces that the company has successfully completed a directed share issue of approximately SEK 314 million (USD 38 million).

> Read the full press release here

By continuing on the site you accept our terms and conditions for cookies. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.